# US 2015/0148513 A1 · Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148513 A1
- Document ID: US20150148513A1
- Status: Published application
- Kind: A1
- Application number: 14/405,390
- Filed: 2013-06-03
- Published: 2015-05-28
- Earliest claimed: 2012-06-04
- Assignees: Genomatica, Inc.
- Applicants: Genomatica, Inc.
- Inventors: Priti Pharkya; Anthony P. Burgard; Stephen J. Van Dien; Robin E. Osterhout; Mark J. Burk; John D. Trawick; Michael P. Kuchinskas; Brian Steer
- Web page: https://patentgrep.com/patent/US20150148513A1

## CPC

- C12N 1/20: Bacteria; Culture media therefor
- C07C 31/207: {1,4-Butanediol; 1,3-Butanediol; 1,2-Butanediol; 2,3-Butanediol}
- C07C 59/01: Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C08G 18/284: {Compounds containing ester groups, e.g. oxyalkylated monocarboxylic acids}
- C08G 18/3206: {aliphatic}
- C08G 63/06: derived from hydroxycarboxylic acids
- C08G 63/16: Dicarboxylic acids and dihydroxy compounds
- C08G 63/181: Acids containing aromatic rings
- C08G 69/02: Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C12N 1/14: Fungi (culture of mushrooms A01G18/00; as new plants A01H15/00); Culture media therefor
- C12N 1/16: Yeasts; Culture media therefor
- C12N 9/18: Carboxylic ester hydrolases {(3.1.1)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12P 7/18: polyhydric
- C12P 7/42: Hydroxy-carboxylic acids
- C12Y 301/01: Carboxylic ester hydrolases (3.1.1)
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate, 1,4-butanediol, or other product pathway and being capable of producing 4-hydroxybutyrate, 1,4-butanediol, or other product, wherein the microbial organism comprises one or more genetic modifications. The invention additionally provides methods of producing 4-hydroxybutyrate, 1,4-butanediol, or other product or related products using the microbial organisms.

## Claims

### Claim 1

A non-naturally occurring microbial organism, said microbial organism having a 4-hydroxybutyrate pathway and being capable of producing 4-hydroxybutyrate, wherein said microbial organism comprises a genetic modification, said genetic modification selected from:
(A) a genetic modification that increases expression of phosphoenolpyruvate carboxylase;
(B) a genetic modification that increases expression of alpha-ketoglutarate dehydrogenase;
(C) a genetic modification that increases expression of a non-phosphotransferase (PTS) glucose uptake system;
(D) a genetic modification that increases expression of a gamma-butyrolactone esterase;
(E) a genetic modification that decreases expression of succinyl-CoA synthetase;
(F) a genetic modification that decreases expression of an acyl coenzyme A thioesterase;
(G) a genetic modification that decreases expression of an alcohol dehydrogenase;
(H) a genetic modification that decreases expression of a non-energy-producing NADH dehydrogenase;
(I) a genetic modification that decreases expression of a cytochrome oxidase; and
(J) a combination of two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, or all of the genetic modifications of parts (A)-(I).

### Claim 2 (depends on 1)

The microbial organism of claim 1, wherein said microbial organism of parts (D) or (F) further comprises a 4-hydroxybutyryl-CoA pathway.

### Claim 3 (depends on 1)

The microbial organism of claim 1, wherein said microbial organism further comprises a 1,4-butanediol pathway.

### Claim 4 (depends on 1)

The microbial organism of claim 1, further comprising a metabolic modification selected from:
(i) a genetic modification that increases expression of pyruvate dehydrogenase;
(ii) a genetic modification that decreases expression of an aerobic respiratory control regulatory system;
(iii) a genetic modification that increases expression of an NADH insensitive citrate synthase;
(iv) a genetic modification that decreases expression of malate dehydrogenase;
(v) a genetic modification that decreases expression of lactate dehydrogenase;
(vi) a genetic modification that decreases expression of alcohol dehydrogenase;
(vii) a genetic modification that decreases expression of pyruvate formate lyase; and
(viii) a combination of two or more, three or more, four or more, five or more, six or more, or all of the genetic modifications of parts (i)-(vii).

### Claim 5 (depends on 1)

The microbial organism of claim 1, wherein the microbial organism comprises metabolic modifications selected from Table 62, Table 63 or FIG. 91.

### Claim 6 (depends on 1)

The microbial organism of claim 1, wherein:
(K) the microbial organism of part (A), (B) or (C) has decreased production of ethanol, acetate, pyruvate or alanine, or a combination thereof, relative to a parent microbial organism in the absence of said genetic modification;
(L) the microbial organism of part (B) has decreased production of glutamate relative to a parent microbial organism in the absence of said genetic modification;
(M) the microbial organism of part (C) has a genetic modification comprising increased expression of a permease, glucokinase, or a glucose facilitator, or a combination thereof;
(N) the microbial organism of part (D) has decreased production of gamma-butyrolactone relative to a parent microbial organism in the absence of said genetic modification;
(O) the microbial organism of part (E) has increased production of 4-hydroxybutyrate relative to a parent microbial organism in the absence of said genetic modification;
(P) the microbial organism of part (F) has decreased production of gamma-butyrolactone relative to a parent microbial organism in the absence of said genetic modification;
(Q) the microbial organism of part (F) has a genetic modification comprising at least two genetic modifications that decrease expression of at least two acyl coenzyme A thioesterases;
(R) the microbial organism of part (G) has decreased backflux from a downstream product of the 4-hydroxybutyrate pathway relative to a parent microbial organism in the absence of said genetic modification;
(S) the microbial organism of part (H) has suppressed depletion of the NADH pool or increased energy efficiency in the microbial organism, or a combination thereof, relative to a parent microbial organism in the absence of said genetic modification;
(T) the microbial organism of part (I) has increased energy efficiency relative to a parent microbial organism in the absence of said genetic modification; or
(U) the microbial organism of part (I) has increased tolerance to a range of oxygen concentrations relative to a parent microbial organism in the absence of said genetic modification.

### Claim 7 (depends on 1)

A method for producing 4-hydroxybutyrate, comprising culturing the non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce 4-hydroxybutyrate.

### Claim 8 (depends on 3)

A method for producing 1,4-butanediol, comprising culturing the non-naturally occurring microbial organism of claim 3 under conditions and for a sufficient period of time to produce 1,4-butanediol.

### Claim at position 9

9-10. (canceled)

### Claim 11 (depends on 3)

A method for producing isolated or purified 4-hydroxybutyrate or 1,4-butanediol, comprising culturing the non-naturally occurring microbial organism of claim 3 under conditions and for a sufficient period of time to produce 4-hydroxybutyrate or 1,4-butanediol, and isolating or purifying the 4-hydroxybutyrate or 1,4-butanediol.

### Claim 12 (depends on 11)

The method of claim 11, wherein the isolating or purifying comprises distillation.

### Claim 13 (depends on 1)

Culture medium comprising bioderived 4-hydroxybutyrate or 1,4-butanediol, wherein said bioderived 4-hydroxybutyrate or 1,4-butanediol has a carbon-12, carbon-13 and carbon-14 isotope ratio that reflects an atmospheric carbon dioxide uptake source and is produced by the microbial organism of claim 1.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

Bioderived 4-hydroxybutyrate or 1,4-butanediol having a carbon-12, carbon-13 and carbon-14 isotope ratio that reflects an atmospheric carbon dioxide uptake source and is produced by the microbial organism of claim 1.

### Claim 16 (depends on 15)

The bioderived 4-hydroxybutyrate or 1,4-butanediol of claim 15, wherein said bioderived 4-hydroxybutyrate or 1,4-butanediol has an Fm value of at least 80%, at least 85%, at least 90%, at least 95% or at least 98%.

### Claim 17 (depends on 7)

Bioderived 4-hydroxybutyrate or 1,4-butanediol produced according to the method of claim 7.

### Claim 18 (depends on 15)

A composition comprising said bioderived 4-hydroxybutyrate or 1,4-butanediol of claim 15 and a compound other than said bioderived 4-hydroxybutyrate or 1,4-butanediol.

### Claim 19 (depends on 18)

The composition of claim 18, wherein said compound other than said bioderived 4-hydroxybutyrate or 1,4-butanediol is a cellular portion of a non-naturally occurring microbial organism having a 4-hydroxybutyrate or 1,4-butanediol pathway.

### Claim 20 (depends on 15)

A composition comprising the bioderived 4-hydroxybutyrate or 1,4-butanediol of claim 15, or a cell lysate or culture supernatant thereof.

### Claim 21 (depends on 15)

A biobased product comprising said bioderived 4-hydroxybutyrate or 1,4-butanediol of claim 15, wherein said biobased product is a plastic, elastic fiber, polyurethane, polyester, polyhydroxyalkanoate, poly-4-hydroxybutyrate (P4HB), or a co-polymer thereof, poly(tetramethylene ether) glycol (PTMEG), polybutylene terephthalate (PBT), polyurethane-polyurea copolymer, or nylon.

### Claim 22 (depends on 21)

The biobased product of claim 21, comprising at least 5%, at least 10%, at least 20%, at least 30%, at least 40% or at least 50% bioderived 4-hydroxybutyrate or 1,4-butanediol.

### Claim 23

(canceled)

### Claim 24 (depends on 21)

A molded product obtained by molding a biobased product of claim 21.

### Claim 25 (depends on 21)

A process for producing a biobased product of claim 21, comprising chemically reacting said bioderived 4-hydroxybutyrate or 1,4-butanediol with itself or another compound in a reaction that produces said biobased product.

### Claim 26

A method for reducing gamma-butyrolactone production in a cell or cell culture, comprising expressing in the cell a nucleic acid encoding a gamma-butyrolactone esterase.

### Claim 27

(canceled)

### Claim 28 (depends on 26)

The method of claim 26, comprising expressing in the cell a nucleic acid encoding the amino acid sequence of SEQ ID NO:179, or a nucleic acid encoding a polypeptide having at least 90% identity to SEQ ID NO:179.
